Literature DB >> 16389367

Twenty questions on atherosclerosis.

W C Roberts1.   

Abstract

Entities:  

Year:  2000        PMID： 16389367      PMCID： PMC1312295          DOI： 10.1080/08998280.2000.11927657

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN： 0899-8280


× No keyword cloud information.
  29 in total

1.  We think we are one, we act as if we are one, but we are not one.

Authors:  W C Roberts
Journal:  Am J Cardiol       Date:  1990-10-01       Impact factor: 2.778

2.  Can life-style changes reverse coronary atherosclerosis?

Authors:  D Ornish
Journal:  Hosp Pract (Off Ed)       Date:  1991-05-15

Review 3.  Consensus statement: Role of therapy with "statins" in patients with hypertriglyceridemia.

Authors:  S M Grundy
Journal:  Am J Cardiol       Date:  1998-02-26       Impact factor: 2.778

4.  The rule of 5 and the rule of 7 in lipid-lowering by statin drugs.

Authors:  W C Roberts
Journal:  Am J Cardiol       Date:  1997-07-01       Impact factor: 2.778

5.  Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators.

Authors:  B Pitt; D Waters; W V Brown; A J van Boven; L Schwartz; L M Title; D Eisenberg; L Shurzinske; L S McCormick
Journal:  N Engl J Med       Date:  1999-07-08       Impact factor: 91.245

6.  Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study.

Authors:  T R Pedersen; K Berg; T J Cook; O Faergeman; T Haghfelt; J Kjekshus; T Miettinen; T A Musliner; A G Olsson; K Pyörälä; G Thorgeirsson; J A Tobert; H Wedel; L Wilhelmsen
Journal:  Arch Intern Med       Date:  1996-10-14

Review 7.  The cholesterol facts. A summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. A joint statement by the American Heart Association and the National Heart, Lung, and Blood Institute. The Task Force on Cholesterol Issues, American Heart Association.

Authors:  J C LaRosa; D Hunninghake; D Bush; M H Criqui; G S Getz; A M Gotto; S M Grundy; L Rakita; R M Robertson; M L Weisfeldt
Journal:  Circulation       Date:  1990-05       Impact factor: 29.690

8.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

Authors:  F M Sacks; M A Pfeffer; L A Moye; J L Rouleau; J D Rutherford; T G Cole; L Brown; J W Warnica; J M Arnold; C C Wun; B R Davis; E Braunwald
Journal:  N Engl J Med       Date:  1996-10-03       Impact factor: 91.245

9.  Reducing the risk of coronary events: evidence from the Scandinavian Simvastatin Survival Study (4S).

Authors:  J Kjekshus; T R Pedersen
Journal:  Am J Cardiol       Date:  1995-09-28       Impact factor: 2.778

10.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Authors:  J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard
Journal:  N Engl J Med       Date:  1995-11-16       Impact factor: 91.245
View more
  3 in total

Review 1.  Human heart failure with preserved ejection versus feline cardiomyopathy: what can we learn from both veterinary and human medicine?

Authors:  Valentine Prat; Bertrand Rozec; Chantal Gauthier; Benjamin Lauzier
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

2.  Facts and ideas from anywhere.

Authors:  William Clifford Roberts
Journal:  Proc (Bayl Univ Med Cent)       Date:  2017-07

3.  Pre-treatment with simvastatin prevents the induction of diet-induced atherosclerosis in a rabbit model.

Authors:  Nikolaos Oikonomidis; Nikolaos Kavantzas; Laskarina-Maria Korou; Panagiotis Konstantopoulos; Vasilios Pergialiotis; Evangelos Misiakos; Ioannis Rizos; Christos Verikokos; Despina N Perrea
Journal:  Biomed Rep       Date:  2016-10-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.